Intraoperative Continuous Lidocaine Infusion in Laparoscopic Liver Surgery

NANot yet recruitingINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

March 2, 2027

Study Completion Date

May 30, 2027

Conditions
Postoperative Pain After Laparoscopic Liver Resection
Interventions
DRUG

lidocaine infusion

The lidocaine group will receive initial intravenous bolus dose of 1.5mg/kg lidocaine over 10 min, followed by a continuous infusion of 1.5 mg/kg/h lidocaine until the end of surgery. The dose of lidocaine will be calculated according to ideal body weight. The placebo group will be administered normal saline at the same volume, infusion rate and timing.

OTHER

Placebo

The placebo group will be administered normal saline 0.9% at the same volume, infusion rate and timing as lidocaine in the lidocaine group

All Listed Sponsors
lead

Medical University of Warsaw

OTHER